Security key
695127100
Pacira BioSciences, Inc. - Common Stock (PCRX)
CUSIP: 695127100
Q3 2014 13F Holders as of 30 Sep 2014
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 38,686,756
- Total 13F value
- $3,749,136,189
- Share change
- +1,000,170
- Put/Call ratio
- 143%
- SEC-reported price per share
- $96.92
- Number of holders
- 205
- Value change
- +$100,496,443
- Number of buys
- 116
- Number of sells
- 85
- Shares outstanding
- 40,532,351
Holder snapshot
7 facts
Show 1 more fact
Security identity
1 fact
Report period
Q3 2014
Institutions
205
Top holders
10
PCRX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2014
Previous quarter: Q2 2014
Pacira BioSciences, Inc. SEC filings
Pacira BioSciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 695127100
Recent filing periods:
Ownership snapshot
Top reported holders of PCRX - Pacira BioSciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PRICE T ROWE ASSOCIATES I...
Disclosed value leader
PRICE T ROWE ASSOCIATES I...
Comparable rows
15/15
Latest evidence
30 Jun 2014
13F
Lead comparable stake: 12%
Showing 1-6 of 15 holder rows.
Quick read
PRICE T ROWE ASSOCIATES INC /MD/ leads the comparable SEC ownership view at 12%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
PRICE T ROWE ASSOCIATES INC /MD/
12%
GILDER GAGNON HOWE & CO LLC
8.1%
FMR LLC
7.7%
JENNISON ASSOCIATES LLC
6.2%
VANGUARD GROUP INC
5.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
12%
|
$434,197,000
4,726,726 shares
|
— | 30 Jun 2014 |
| GILDER GAGNON HOWE & CO LLC |
13F
Company
|
8.1%
|
$300,722,000
3,273,703 shares
|
— | 30 Jun 2014 |
| FMR LLC |
13F
Company
|
7.7%
|
$285,388,000
3,106,782 shares
|
— | 30 Jun 2014 |
| JENNISON ASSOCIATES LLC |
13F
Company
|
6.2%
|
$232,398,000
2,529,910 shares
|
— | 30 Jun 2014 |
| VANGUARD GROUP INC |
13F
Company
|
5.1%
|
$191,080,000
2,080,115 shares
|
— | 30 Jun 2014 |
| BlackRock Fund Advisors |
13F
Company
|
3.3%
|
$124,427,000
1,354,524 shares
|
— | 30 Jun 2014 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2014
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
205
Shares
38,686,756
Rows available
205
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2014 vs Q2 2014 Across Filers
Q2 2014 holders
190
Q3 2014 holders
205
Holder diff
15
| Investor | Q2 2014 Shares | Q3 2014 Shares | Share Diff | Share Chg % | Q2 2014 value | Q3 2014 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend